K. Spittaels et al., Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein, AM J PATH, 155(6), 1999, pp. 2153-2165
Citations number
68
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Mutations in the human tau gene cause frontotemporal dementia and parkinson
ism linked to chromosome 17, Some mutations, including mutations in intron
10, induce increased levels of the functionally normal four-repeat tau prot
ein isoform, leading to neurodegeneration, We generated transgenic mice tha
t overexpress the four-repeat human tau protein isoform specifically in neu
rons. The transgenic mice developed axonal degeneration in brain and spinal
cord. In the model, axonal dilations with accumulation of neurofilaments,
mitochondria, and vesicles were documented. The axonopathy and the accompan
ying dysfunctional sensorimotor capacities were transgene-dosage related. T
hese findings proved that merely increasing the concentration of the four-r
epeat tau protein isoform is sufficient to injure neurons in the central ne
rvous system, without formation of intraneuronal neurofibrillary tangles. E
vidence for astrogliosis and ubiquitination of accumulated proteins in the
dilated part of the axon supported this conclusion. This transgenic model,
overexpressing the longest isoform of human tau protein, recapitulates feat
ures of known neurodegenerative diseases, including Alzheimer's disease and
other tauopathies. The model makes it possible to study the interaction wi
th additional factors, to be incorporated genetically, or with other biolog
ical triggers that are implicated in neurodegeneration.